142 related articles for article (PubMed ID: 16204032)
21. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
22. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
24. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
25. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
26. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
27. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
[TBL] [Abstract][Full Text] [Related]
28. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing of the tumor suppressor klotho in human breast cancer.
Rubinek T; Shulman M; Israeli S; Bose S; Avraham A; Zundelevich A; Evron E; Gal-Yam EN; Kaufman B; Wolf I
Breast Cancer Res Treat; 2012 Jun; 133(2):649-57. PubMed ID: 22042362
[TBL] [Abstract][Full Text] [Related]
30. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Ferguson AT; Lapidus RG; Baylin SB; Davidson NE
Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
[TBL] [Abstract][Full Text] [Related]
32. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
[TBL] [Abstract][Full Text] [Related]
35. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists.
Kusakabe M; Watanabe K; Emoto N; Aki N; Kage H; Nagase T; Nakajima J; Yatomi Y; Ohishi N; Takai D
Biochem Biophys Res Commun; 2009 Dec; 390(4):1283-7. PubMed ID: 19878646
[TBL] [Abstract][Full Text] [Related]
36. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
37. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
39. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
[TBL] [Abstract][Full Text] [Related]
40. Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
